Back to search
FDAFDA · Food and drugs·Recall number D-0593-2026

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

Published June 24, 2026 · Recall initiated: May 18, 2026

Summary

FDA records drug Class II recall D-0593-2026, published June 24, 2026 and initiated May 18, 2026. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 287 units; Lot: Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
IntegraDose Compounding Services LLC
Distributor
U.S.A. Nationwide
Lot
Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1. recalled?

Yes. FDA published recall D-0593-2026 on June 24, 2026. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter